Is serum hornerin a potential biomarker in fibromyalgia? A pilot study

Abstract

The study aims to investigate the relationship between serum hornerin levels and disease severity and pain scores and to evaluate hornerin’s potential as a biomarker and its role in understanding the etiopathogenesis of fibromyalgia (FM).

Keywords

• biomarker
• central sensitization
• fibromyalgia syndrome
• hornerin
• s100 protein family